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INTRODUCTION
The increasing incidence of end-stage renal disease 
(ESRD) is a global problem. Information from the 
United States Renal Data System show that the inci-
dence and prevalence of ESRD is on a slow rising trend. 
ESRD prevalence grew most quickly among those 
aged ≥ 65 [1]. A significant proportion of them also suffered 
from diabetes mellitus with multiple vascular complica-
tions. Not all patients would benefit from dialytic 
therapy as it has been shown that patient survival is 
extremely poor in those with poor functional abilities at 
the commencement of dialysis [2]. It has also been dem-
onstrated that patients with ESRD, poor functional 
status and extensive comorbidities do not live longer with 
dialysis when compared with those managed conserva-
tively. In addition, such patients require frequent admis-
sions for stabilization, and are more likely to die in 
hospital during these admissions [3]. A recent study has 
demonstrated substantial and sustained decline in func-
tional status among nursing home residents after the 
start of dialysis, which may be related to underlying 
processes of aging with disabilities and coexisting con-
ditions [4]. In-depth and repeated discussions on plans 
during renal replacement therapy (RRT) assessment are 
essential for making the best and most suitable choices 
for individual patients. With thorough discussion among 
different parties including patients, their families and 
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clinical staff, patients may choose not to initiate dialysis. 
A recent survey found that 60.7% of patients receiving 
dialysis regretted the decision to start dialysis [5].
Our institution has a structured program of patient 
assessment for dialysis. All patients with chronic kidney 
disease [glomerular filtration rate (GFR) < 15 mL/min/
1.73 m2 for those with diabetes mellitus, or < 10 mL/
min/1.73 m2 for those without diabetes mellitus] are 
assessed by nephrologists and dedicated renal nurses, 
with multidimensional evaluation in terms of comorbid 
conditions, functional status, family condition, social 
support network, as well as financial situation. Patients 
attend a predialysis education program that is presented 
by different professionals, including nephrologists, renal 
nurses, dietitians, social workers, physiotherapists and 
patient group representatives. This helps to ensure ad-
equate understanding and appropriate attitudes towards 
ESRD. Follow-up arrangements are made after indi-
vidual assessments by renal nurses in the clinic. During 
the assessment, close family members are invited to join 
in the discussion on the long-term management plan. 
Their concerns about the disease process and anticipated 
difficulties are identified, any misconceptions clarified, 
and acceptance of the disease evaluated before any final 
decisions are made on RRT plans. Reassessments may be 
lengthy, and involve multiple sessions by nephrologists 
and/or renal nurses. Case review programs, involving 
social workers, dialysis staff and community nurses, are 
held regularly to discuss RRT plans in a holistic manner. 
For patients who opt for dialysis, dialysis access creation 
is arranged in a timely manner. Patients who opt for 
supportive management are followed in a designated 
clinic, namely the Renal Palliative Care Clinic, where 
they are under the care of nephrologists according to 
the main objectives of ensuring better control of disturb-
ing uremic symptoms, more flexible follow-up appoint-
ments for drug titration as well as blood transfusion 
whenever necessary.
This retrospective review reports on the outcomes of 
incident patients with ESRD in 2008 who opted for sup-
portive management, with a specific focus on symptom 
burden from advanced uremia and end-of-life care.
PATIENTS AND METHODS
This was a retrospective observational study on consecu-
tive new patients with ESRD who were referred for dialy-
sis assessment between January 1, 2008 and December 
31, 2008 in the Renal Unit of United Christian Hospital. 
The inclusion criterion was GFR < 15 mL/min/1.73 m2 
for patients with diabetes mellitus, or < 10 mL/min/1.73 m2 
for patients without diabetes mellitus, according to the 
Chinese version of the modified Modification of Diet in 
Renal Disease formula [6]. Exclusion criteria were: pre-
mature referral for RRT assessment due to higher GFR 
(non-diabetic patient with GFR > 10 mL/min/1.73 m2 or 
diabetic patient with GFR > 15 mL/min/1.73 m2); and 
the presence of a component of acute renal impairment. 
There was no limitation on age or comorbidities for 
patients to be eligible for study inclusion.
Baseline demographic data on age, sex, primary renal 
disease, coexisting medical conditions, Charlson Co-
morbidity Index, laboratory data, calculated GFR, and date 
of RRT assessment were recorded. In addition, the 
symptomatology reported by patients, without using 
questionnaires, on every clinic visit until December 31, 
2009, were recorded by chart review. Causes of death 
were reviewed, with special attention paid to cardiopul-
monary resuscitation (CPR) and do-not-resuscitate (DNR) 
orders, which reflected patients’ and families’ accep-
tance of the disease process and the quality of death.
Results were analyzed using NCSS 2004 (NCSS LLC, 
Kaysville, UT, USA) for PC. Student’s t test for con-
tinuous data, and the χ2 test or Fisher’s exact test for 
categorical data were applied whenever appropriate. 
Kaplan-Meier curves were plotted for estimation of me-
dian survival for patients on supportive management.
RESULTS
There were 225 new chronic kidney disease stage 5 pa-
tients referred for RRT assessment. Nine patients were 
considered to have been prematurely referred for assess-
ment, and three patients were diagnosed to have acute-
on-chronic renal failure; they were excluded from analysis. 
The remaining 213 patients were included in the study; 
the most common causes of chronic kidney disease in 
these patients were diabetic nephropathy and unknown 
etiology (Table 1). Seventy-four patients opted for sup-
portive management, while the remaining 139 patients 
proceeded to dialysis. Only one patient was staying in 
a private old age home at the time of RRT assessment, 
and he opted for supportive management.
Table 1. Causes of end-stage renal disease
 Supportive Dialysis
 management (n = 74) (n = 139)
Diabetic nephropathy 50 64
Chronic glomerulonephritis 1 23
Hypertensive nephropathy 2 2
Myeloma 1 1
Obstructive uropathy 1 5
Polycystic kidney disease 1 2
Rapidly progressive 1 0
 glomerulonephritis
Thrombotic microangiopathy 1 0
Renal malignancy 0 2
Systemic lupus nephritis 0 1
Etiology unknown 16 39
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The baseline characteristics of the study cohort, i.e. 
those who opted for supportive management, as well as 
those of the dialysis group, are shown in Table 2. There 
was a female preponderance in both the study cohort and 
dialysis group. Patients in the supportive management 
group were older (p < 0.001), more likely to have dia-
betes mellitus as a primary renal diagnosis (p = 0.016), a 
history of congestive heart failure (p = 0.029) and a history 
of cerebrovascular accident (p < 0.001) compared to 
patients in the dialysis group. There was a similar per-
centage of patients with a history of acute myocardial 
infarction in the two groups. The mean Charlson Co-
morbidity Index of the supportive management group 
was 2 points higher than that of the dialysis group 
(p < 0.001). Mean eGFR was also higher (p = 0.004) in 
the supportive management group than in the dialysis 
group, which may be the result of the supportive man-
agement group having a higher percentage of diabetic 
patients who required initiation of RRT assessment at 
higher GFR. Hence, mean serum creatinine level was 
significantly lower (p = 0.005) in the supportive manage-
ment group.
The reported reasons for choosing supportive man-
agement are summarized in Table 3, although it should 
be borne in mind that patients may have multiple un-
stated reasons on which they base their decision. The 
commonest reasons reported were poor social support 
(28.4%), being too old to start dialysis (27.0%), and 
non-acceptance of dialytic therapy (24.3%).
The most commonly reported symptoms by patients 
in the supportive management group are summarized 
in Table 4 [7,8], which includes data from other studies 
for comparison. Among the eight patients who reported 
pain as a presenting symptom, three had frequent gout 
attacks during assessment, one suffered from trigeminal 
neuralgia, one described classical angina, one had mul-
tiple musculoskeletal pain involving the knees, wrists 
and chest wall, one had prostate carcinoma with rectal 
Table 2. Baseline characteristics of patients in the supportive management and dialysis groups
 Supportive Dialysis Total p
 management (n = 74) (n = 139) (n = 213)
Mean age (yr) 72.3 60.2 64.4 < 0.001
Median age (yr) 73.8 62.4 66.4 
Male:Female (n) 26:48 55:84 81:132 0.526
Serum creatinine (μmol/L) (mean ± SD) 667 ± 303 769 ± 305 734 ± 307 0.005
eGFR (mL/min/1.73 m2) at assessment 10.71 ± 6.77 8.76 ± 4.02 9.43 ± 5.21 0.004
 (mean ± SD)
CCI (mean ± SD) 7.4 ± 1.92 5.4 ± 2.12 6.12 ± 2.27 < 0.001
Comorbid DM* 50 (67.57%) 70 (50.36%) 120 (56.34%) 0.016
History of MI* 18 (24.32%) 23 (16.55%) 41 (19.25%) 0.171
History of CHF* 21 (28.38%) 22 (15.83%) 43 (20.19%) 0.029
PVD* 6 (8.11%) 1 (0.72%) 7 (3.29%) 0.007
History of CVA* 26 (35.14%) 14 (10.07%) 40 (18.78%) < 0.001
Dementia* 1 (1.35%) 0 (0%) 0 (0%) 
Chronic pulmonary disease* 6 (8.11%) 6 (4.32%) 12 (5.63%) 0.253
Peptic ulcer disease* 9 (12.16%) 11 (7.91%) 20 (9.39%) 
Liver disease without portal hypertension* 1 (1.35%) 0 (0%) 1 (0.47%) 
Lymphoma* 2 (2.70%) 0 (0%) 2 (0.94%) 
Leukemia* 0 (0%) 0 (0%) 0 (0%) 
Metastatic tumor* 1 (1.35%) 0 (0%) 1 (0.47%) 
Connective tissue disease* 0 (0%) 1 (0.72%) 1 (0.47%) 
Severe liver disease* 0 (0%) 0 (0%) 0 (0%) 
AIDS* 0 (0%) 0 (0%) 0 (0%) 
*Percentage within group in parentheses. SD = standard deviation; eGFR = estimated glomerular filtration rate; CCI = Charlson 
Comorbidity Index; DM = diabetes mellitus; MI = myocardial infarction; CHF = congestive heart failure; PVD = peripheral vascular 
disease; CVA = cerebrovascular accident. 
Table 3. Reasons for choosing supportive management over dialysis 
given by the 74 patients in the study cohort*
 Frequency of 
 response, n (%)
Patient’s perception that 20 (27.0)
 they were too old for RRT
Patient not accepting dialysis therapy 18 (24.3)
Multiple comorbidities with 16 (21.6)
 poor functional state
Perceived as a burden to the family 3 (4.1)
Poor social support 21 (28.4)
Other 13 (17.6)
*Patients could give more than one reason. RRT = renal replace-
ment therapy.
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invasion causing persistent pain over the pelvic region, 
and one had pain reported during the clinic visit but 
without further details recorded on the chart. They were 
all managed accordingly.
Concerning outpatient management, 23 patients 
(31.1%) in the study cohort were followed by neph-
rologists in the Renal Palliative Care Clinic, which had 
been set up in the middle of 2008. Of these 23 patients, 
six (8.1% of total study cohort) received erythropoietin 
injection, and four (5.4%) received androgen injection 
for correction of renal anemia. In addition, 15 (20.3%) 
received active vitamin D for parathyroid hormone 
suppression or correction of hypocalcemia.
Median survival in the supportive management group 
was 7.1 months (95% confidence interval, 5.0–9.7 months) 
(Figure). Five patients died within 2 weeks after 
RRT assessment. Another five patients died within the 
latter half of the first month after RRT assessment, 
representing late presentation of the disease or significant 
comorbidities. Fifty-one patients (68.9%) died within the 
first year after RRT assessment. The patient who was 
living in the private old age home at the time of RRT 
assessment remained well with supportive management, 
and died of acute myocardial infarction 5 months after 
RRT assessment.
Over the course of the follow-up study period (up 
to December 31, 2009), 60 of the 74 patients in the study 
cohort died. The most common causes of death were 
advanced uremia, systemic sepsis and cardiac event 
(Table 5). On review of the records of these 60 patients, 
54 (90%) had DNR orders and their end of life was 
managed with comfort care. Another two patients had 
CPR initially but later changed to DNR after confirming 
the supportive nature of their management plan. The 
final four patients had CPR: three of them experienced 
sudden deterioration requiring admission to another 
hospital or to a surgical unit; one CPR was performed 
as requested by the patient’s family.
DISCUSSION
Supportive care for ESRD patients is different from 
supportive care for patients with terminal malignancies. 
There are always life-sustaining treatments available 
(e.g. dialysis) for renal failure patients, but it may be 
difficult to define who will benefit significantly from 
dialysis. Predicting prognosis is also difficult, making 
it hard to decide on whether or not to go ahead with 
dialysis. For some patients, dialysis may not be a fea-
sible or practical solution to maintain a good quality 
of life.
We have described the RRT assessment for ESRD 
patients who presented in 2008 to our center. We em-
phasize the importance of advanced care planning on 
the initiation of RRT assessment. During the actual RRT 
assessment, there is an emphasis on shared decision-
making among patients, family members, renal physicians, 
Table 4. Symptoms reported by patients in the supportive management group
Symptom
 This study (n = 74)  Yong et al [7] (n = 45) Saini et al [8] (n = 11)
 n (%) % %
Dependent edema 37 (50.0) 31.1  73
Malaise and lethargy 30 (40.5) 68.9 100
Anorexia 28 (37.8) 28.9  55
Pruritus 24 (32.4) 57.8  55
Nausea and vomiting 17 (23.0) 11.1 9 (as difficulty in
    swallowing)
Pain  8 (10.8) 48.9  64
Insomnia 1 (1.4) 48.9  82
Cramps 0 (0) 33.3  64
Numbness 0 (0) 42.2  64
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Figure. Kaplan-Meier curve of patient survival in the supportive 
management group.
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dedicated renal nurses and social workers. Patients and 
their family members are empowered to make important 
decisions on treatment options after they are provided 
with adequate information. The available dialysis mo-
dalities (continuous ambulatory peritoneal dialysis, 
automated peritoneal dialysis, hemodialysis) and non-
dialytic supportive management with end-of-life care 
should always be discussed explicitly during the assess-
ment [9]. This is of paramount importance as information-
giving rectifies misconceptions, addresses uncertainties 
and fears, and provides patients and their families with 
insight into their illnesses, encouraging subsequent 
willingness to accept the formulated treatment [10]. 
They would then be better prepared for the course of 
their illness and subsequent deterioration, including 
death. They would have an appropriate management 
target geared towards symptom relief rather than a day-
to-day approach. Repeat assessments are essential to 
identify a patient’s needs and hopes before a firm com-
mitment is made on a specific treatment plan. The pa-
tient’s preference should be respected, and changes in 
preference should also be respected, especially for those 
who can demonstrate the rational thinking behind the 
change [11].
The incidence of the various symptoms reported by 
our patients on supportive care was, in general, lower 
compared to Western data (Table 4). This could be the 
result of differences in study design, such as under-
reporting in retrospective non-questionnaire based 
studies, and biases posed by clinicians. This was par-
ticularly true for the less common and usually neglected 
symptoms such as insomnia, cramps, numbness and rest-
less legs. From the Yong et al study [7], which was a 
questionnaire-based study conducted in Hong Kong, these 
symptoms were less prevalent compared to Western data. 
A likely explanation for this finding may be the differ-
ences in cultures. Symptom perceptions and burdens 
are known to be heavily influenced by cultural differ-
ences [12]. Further studies on symptomatology, espe-
cially on the longitudinal progression of these symptoms 
with respect to the disease trajectory, are important in 
the management of patients on supportive care as symp-
tom control is an essential element. In addition, we noted 
the under-utilization of erythropoiesis stimulating agents 
or androgen injections, both of which can improve sym-
ptom control by correction of renal anemia. Alterna-
tively, blood transfusion as required can serve the same 
purpose.
In this study, we found that a high number of patients 
on supportive care chose to institute DNR orders. We 
believe this to be an illustration of the success of ad-
vanced care planning during RRT assessment and of the 
continuous support during follow-up. Patients had an-
ticipated death and knew what to expect. They retained 
a sense of control over their choices and had their wishes 
respected. Moreover, 56.7% of patients died due to 
causes unrelated to uremia (i.e. due to sepsis, cardiac 
events and cerebrovascular accident; Table 5), and pa-
tients on supportive care in this part of the world are 
admitted to hospital for final events.
Supportive management of ESRD patients who 
opt against dialysis is at an early stage of development, 
with plenty of room for growth and improvement, such 
as better collaboration among nephrologists, renal 
nurses, social workers, palliative care physicians and pal-
liative care nurses. The provision of community services, 
end-of-life care and bereavement services are also in-
tegral parts of care delivery. There is a need for palliative 
care training in the nephrology training curriculum, and 
a need for nephrology training in the palliative care train-
ing curriculum, as the two subspecialties com plement 
each other in the supportive care of ESRD patients.
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